Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FA4R8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,085
Award facts
- Contract value 100% obligated
- $49,085.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $49,085.46 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Ozempic 0.25-0.5 mg/dose pen 3ml pharmaceutical products on February 4, 2026, with an ultimate completion date of February 5, 2026. The contract is unclassified as a set-aside and will be performed at the awardee's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The parent company holds a significant single-award Indefinite Delivery Contract with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2031. As a competitively awarded, non-set-aside contractor, AmerisourceBergen demonstrates substantial capability in fulfilling federal pharmaceutical supply requirements across multiple therapeutic domains, including diabetes medications, specialty treatments, and medical supplies for military treatment facilities and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FA4R8?
SPE2DR26FA4R8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 4, 2026.
How much is contract SPE2DR26FA4R8 worth?
The government has obligated $49,085 on SPE2DR26FA4R8.
Is contract SPE2DR26FA4R8 an order under another contract?
Yes. SPE2DR26FA4R8 is a delivery order under SPE2DR25D2014, an indefinite delivery contract.
Was contract SPE2DR26FA4R8 competed?
The extent of competition for SPE2DR26FA4R8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award